$エレベーション(ELEV.US)$$メリマック ファーマシューティカルズ(MACK.US)$Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan MT Newswires· 2 mins ago Merrimack Pharmaceuticals (MACK) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution. The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...
2
2
報告
Jaguar8 :
I love the milestone payment but dissolution weighed it down
Chairman Gary Crocker highlighted that interest income on cash and short term investments helped offset a significant portion of Q3 operating expenses. He also noted the company keeps observing developments in Ipsen's Onivyde(R) and Elevation's seribantumab programs.
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. Top Medical News of the Week $モデルナ(MRNA.US)$'s new Covid booster triggered a stronger immune response against omicron BA.5 and also appears to work against the emerging BQ.1.1 subvariant, according to the company. The U.S. Covid public health emergency will remain in place past Jan. 11 after the federal government did no...
8
2
3
報告
72987343 :
is this pro big pharma dr fauci he should know he helped create the disease killing virus ask him
ilovemoney29 :
i am already out, i suspect may have halt up later. ppl dun understand the significance of these news, lots of misinformation spreading by shorts, but they forgot that hedge funds are also buying into these.
Jaguar8 : I love the milestone payment but dissolution weighed it down
Trytosaveabitスレ主 Jaguar8: Yup! I believe you’re correct